Title of article :
Genetic Engineering in Streptomyces roseosporus to Produce Hybrid Lipopeptide Antibiotics Original Research Article
Author/Authors :
Vivian Miao، نويسنده , , Marie-Francois Coëffet-Le Gal، نويسنده , , Kien Nguyen، نويسنده , , Paul Brian Little، نويسنده , , Julia Penn، نويسنده , , Andrew Whiting، نويسنده , , Jonathan Steele، نويسنده , , David Kau، نويسنده , , Steve Martin، نويسنده , , Robert Ford، نويسنده , , Trevor Gibson، نويسنده , , Mario Bouchard، نويسنده , , Stephen K. Wrigley، نويسنده , , Richard H. Baltz، نويسنده ,
Issue Information :
ماهنامه با شماره پیاپی سال 2006
Pages :
8
From page :
269
To page :
276
Abstract :
Daptomycin is a lipopeptide antibiotic produced by a nonribosomal peptide synthetase (NRPS) in Streptomyces roseosporus. The holoenzyme is composed of three subunits, encoded by the dptA, dptBC, and dptD genes, each responsible for incorporating particular amino acids into the peptide. We introduced expression plasmids carrying dptD or NRPS genes encoding subunits from two related lipopeptide biosynthetic pathways into a daptomycin nonproducing strain of S. roseosporus harboring a deletion of dptD. All constructs successfully complemented the deletion in trans, generating three peptide cores related to daptomycin. When these were coupled with incomplete methylation of 1 amino acid and natural variation in the lipid side chain, 18 lipopeptides were generated. Substantial amounts of nine of these compounds were readily obtained by fermentation, and all displayed antibacterial activity against gram-positive pathogens.
Journal title :
Chemistry and Biology
Serial Year :
2006
Journal title :
Chemistry and Biology
Record number :
1159171
Link To Document :
بازگشت